BIKTARVY
Identification of Biktarvy
| No description |
Google image searchProduct monograph
Active ingredients
bictegravir (bictegravir sodium), 50 MG
emtricitabine, 200 MG
tenofovir alafenamide (tenofovir alafenamide hemifumarate), 25 MG
DIN: 02478579
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: GILEAD SCIENCES CANADA INC
Date: 08-AUG-2018
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AR — Antivirals for treatment of HIV infections, combinations (ATC, ATC/DDD)
- J05AR20 — EMTRICITABINE, TENOFOVIR ALAFENAMIDE AND BICTEGRAVIR (ATC/DDD)
Reference brand drug: Biktarvy
